Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Mounjaro Races Ahead Of Wegovy In India’s Nascent Weight-Loss Drug Market

Summary by News18 India
Eli Lilly’s Mounjaro outpaces Novo Nordisk’s Wegovy in India’s anti-obesity drug market, capturing 96 percent share and driving rapid growth in 2025.

1 Articles

News18 IndiaNews18 India
Lean Right

Mounjaro Races Ahead Of Wegovy In India’s Nascent Weight-Loss Drug Market

Eli Lilly’s Mounjaro outpaces Novo Nordisk’s Wegovy in India’s anti-obesity drug market, capturing 96 percent share and driving rapid growth in 2025.

·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

News18 India broke the news in India on Wednesday, October 8, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eli Lilly icon

Eli Lilly

Wegovy icon

Wegovy

India icon

India

News
For You
SearchBlindspotLocal